|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||252.78 - 255.42|
|52-week range||252.78 - 255.42|
|Beta (5Y monthly)||0.95|
|PE ratio (TTM)||60.81|
|Earnings date||27 Apr 2021|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Stryker (NYSE: SYK) acquired Mako Surgical in 2013. It did so with a plan to combine the company's leadership with Mako's innovative robotic arm assisted surgical products in an effort to transform orthopedics. In 2017, that plan came to fruition with what the company described as a first and only robotic arm assisted technology for total knee and hip replacement procedures.
The Zacks Analyst Blog Highlights: Smith & Nephew, Intuitive Surgical, Stryker Corp, Accuray and Medtronic
Let's keep a watch on the potentially strong three MedTech stocks, namely SYK, ARAY and MDT with respect to robotic-assisted surgery that showed promises during the pandemic.